Mechanisms underlying the Comorbidity between depressive and addictive disorders in Adolescents: interactions between stress and HPA activity

American Journal of Psychiatry

Volumn 166, Issue 3, 2009, Pages 361-369

  Rao, Uma ^a   Hammen, Constance L ^b   Poland, Russell E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COCAINE; HYDROCORTISONE; METYRAPONE; NICOTINE;

ADOLESCENT; ARTICLE; CHILD PSYCHIATRY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SUBSTANCE ABUSE;

ADOLESCENT; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIFE CHANGE EVENTS; MALE; PITUITARY-ADRENAL SYSTEM; POLYSOMNOGRAPHY; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS;

EID: 62949176286     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08030412     Document Type: Article

References (40)

1. Kessler RC, Berglund P, Dernier O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005; 62:593-602
2. Rao U: Development and natural history of pediatric depression: treatment implications. Clinical Neuropsychiatry 2006; 3:194-204
3. Armstrong TD, Costello EJ: Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. Consult Clin Psychol 2002; 70:1224-1239
4. Rao U, Chen L-A: Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents. Curr Drug Abuse Rev 2008; 1:68-80
5. King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L: The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res 2000; 27:417-430
6. Hammen C: Stress and depression. Ann Rev Clin Psychol 2005; 1:293-319
7. Piazza PV, Le Moal M: The role of stress in drug self-administration. Trends Pharmacol Sci 1998; 19:67-74
8. Carter BL, Tiffany ST: Meta-analysis of cue reactivity in addiction research. Addiction 1999; 94:327-340
9. Sinha R: The role of stress in addiction relapse. Curr Psychiatry Rep 2007; 9:388-395
10. Stewart J: Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatr Neurosci 2000; 25:125-136
11. Koob G, Kreek MJ: Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007; 164:1149-1159
12. Meyer SE, Chrousos GP, Gold PW: Major depression and the stress system: a life span perspective. Dev Psychopathol 2001; 13:565-580
13. Holsboer F, Ising M: Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacology 2008; 583:353-357
14. Ladd CO, Huot RL, Thrivkraman KV, Nemeroff CB, Meaney MJ, Plotsky PM: Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res 2000; 122:81-103
15. Heim C, Nemeroff CB: The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 2001; 49:1023-1039
16. Rao U, Daley SE, Hammen C: Relationship between depression and substance use disorders in adolescent women during the transition to adulthood. J Am Acad Child Adolesc Psychiatry 2000; 39:215-222
17. Rao U, Ryan ND, Dahl RE, Birmaher B, Rao R, Williamson DE, Perel JM: Factors associated with the development of substance use disorder in depressed adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38:1109-1117
18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Press, 1994
19. Hamilton M: A rating scale for depression. J Neurol, Neurosurg Psychiatry 1960; 25:56-62
20. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36:980-988
21. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983; 40:1228-1231
22. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
23. Andreasen NC, Endicott J, Spitzer RL, Winokur G: Thefamily history method using diagnostic criteria. Arch Gen Psychiatry 1977; 34:1229-1235
24. Brown GW, Harris T: Social origins of depression: a reply. Psychol Med 1978; 8:577-588
25. Hammen C, Surge D, Daley SE, Davila J, Paley B, Rudolph KD: Interpersonal attachment cognitions and prediction of symptomatic responses to interpersonal stress. J Abnorm Psychol 1995; 104:436-443
26. Poland RE, Rubin RT: Saliva Cortisol levels following dexa-methasone administration in endogenously depressed patients. Life Sci 1982; 30:177-181
27. Shapiro R, Keller M: Longitudinal Interval Follow-Up Evaluation (LIFE). Boston, Massachusetts General Hospital, 1979
28. Lloyd DA, Turner RJ: Cumulative lifetime adversities and alcohol dependence in adolescence and young adulthood. Drug Alcohol Depend 2008; 93:217-226
29. Moss HB, Vanyukov M, Yao JK, Kirillova GP: Salivary Cortisol responses in prepubertal boys: the effects of parental substance abuse and association with drug use behavior during adolescence. Biol Psychiatry 1999; 45:1293-1299
30. Clark DB, Parker AM, Lynch KG: Psychopathology and substance-related problems during early adolescence: a survival analysis. J Clin Child Psychol 1999; 28:333-341
31. Rao U, Poland RE: EEG sleep and HPA changes from episode to recovery in depressed adolescents. J Child Adolesc Psychophar-macol 2008; 18:607-613
32. Meikle AW, Stringham JD, Woodward MG, Bishop DT: Heritability of variation of plasma Cortisol levels. Metabolism 1988; 37: 514-517
33. Funk CK, O'Dell LE, Crawford EF, Koob GF: Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 2006; 26:11324-11332
34. Goeders NE: A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 1997; 22:237-259
35. Fahlke C, Hard E, Thomasson R, Engel J, Hansen S: Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats. Pharmacol Biochem Behav 1994; 48:977-981
36. Piazza PV, Marinelli M, Jodogne C, Deroche V, Rougéé-Pont F, Maccari S, Le Moal M, Simon H: Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 1994; 658:259-264
37. Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, Mackin PL: Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev 2008; 1:CD005168
38. Torrens M, Fonseca F, Mateu G, Farre M: Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and meta-analysis. Drug Alcohol Depend 2005; 78:1-22
39. Duman RS, Malberg J, Thome J: Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 1999; 46:1181-1191
40. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP Jr, Weiss PM, Dunner DL, Rothbaum BO, Kornstein S, Keitner G, Keller MB: Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. PNAS2003; 100:14293-14296